Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-20 4:15 pm Purchase | 2023-01-15 | 13D | Syros Pharmaceuticals, Inc. SYRS | Samsara BioCapital, L.P. | 1,605,546 7.500% | 1,605,546 (New Position) | Filing History |
| 2023-10-18 5:27 pm Purchase | 2023-10-16 | 13D | Scholar Rock Holding Corporation SRRK | Samsara BioCapital, L.P. | 7,878,302 11.000% | 2,202,226 (+38.80%) | Filing History |
| 2023-08-25 4:15 pm Purchase | 2022-04-12 | 13G | Lyra Therapeutics, Inc. LYRA | Samsara BioCapital, L.P. | 55,605 5.600% | 55,605 (New Position) | Filing History |
| 2023-02-24 4:00 pm Purchase | 2023-02-14 | 13D | COMPASS Pathways plc CMPS | Samsara BioCapital, L.P. | 4,521,805 11.100% | 4,521,805 (New Position) | Filing History |
| 2023-02-14 5:07 pm Purchase | 2022-12-31 | 13G | Graphite Bio, Inc. GRPH | Samsara BioCapital, L.P. | 1,213,867 14.600% | 92,162 (+8.22%) | Filing History |
| 2023-02-14 5:05 pm Purchase | 2022-06-22 | 13D | Scholar Rock Holding Corporation SRRK | Samsara BioCapital, L.P. | 5,676,076 10.800% | 5,676,076 (New Position) | Filing History |
| 2023-02-14 5:00 pm Purchase | 2021-04-23 | 13G | Rain Enhancement Technologies Holdco Inc RAIN | Samsara BioCapital, L.P. | 2,260,652 9.100% | 2,260,652 (New Position) | Filing History |
| 2023-02-14 4:56 pm Purchase | 2022-04-28 | 13D | Nkarta, Inc. NKTX | Samsara BioCapital, L.P. | 2,868,035 5.900% | 833,332 (+40.96%) | Filing History |
| 2022-06-01 4:00 pm Purchase | 2020-10-05 | 13D | Chinook Therapeutics, Inc. KDNY | Samsara BioCapital, L.P. | 5,181,557 8.400% | 5,181,557 (New Position) | Filing History |
| 2022-02-14 06:06 am Purchase | 2021-12-31 | 13G | Graphite Bio, Inc. GRPH | Samsara BioCapital, L.P. | 1,121,705 13.500% | 60,044 (+5.66%) | Filing History |
| 2021-07-09 4:31 pm Purchase | 2021-06-29 | 13G | Graphite Bio, Inc. GRPH | Samsara BioCapital, L.P. | 1,061,660 12.800% | 1,061,660 (New Position) | Filing History |